Participants with MetS had higher mean GLP-1 levels than those without MetS and participants in the fourth quartiles for serum GLP-1 had markedly higher odds of MetS compared with those in the bottom quartile (Table 3). The gene discussed is GLP1R; the disease is metabolic syndrome.